Specialist Dr. Dogan Oncu

Academic Title :

Specialist Dr.

Department	Work location
Cancer Treatment Department	ISU Medical Park Gaziosmanpasa

Prof. Dr. Doğan Uncu is a MEDICAL ONCOLOGY specialist at ISU Medical Park Gaziosmanpasa, providing expert and comprehensive care to cancer patients.

Education and Academic Qualifications

Bachelor of Medicine, Faculty of Medicine - Hacettepe Üniversitesi, 1992-1998
Internal Medicine Specialization, Ankara Numune Eğitim ve Araştırma Hastanesi, 1998-2003
Medical Oncology Subspecialty, Ankara Numune Eğitim ve Ara Araştırma Hastanesi, 2003-2006
Associate Professorship in Medical Oncology, Ankara Numune Eğitim ve Araştırma Hastanesi, 2012-2018
Professorship in Medical Oncology, Sağlık Bilimleri Üniversitesi Ankara Numune SUAM, 2018

Education and Administrative Officer in Medical Oncology, Sağlık Bilimleri Üniversitesi Ankara Bilkent Şehir Hastanesi (2019-2025)
Education and Administrative Officer in Medical Oncology, Sağlık Bilimleri Üniversitesi Ankara Numune SUAM (2018-2019)
Lecturer in Medical Oncology, Ankara Numune Eğitim ve Araştırma Hastanesi (2010-2018)
Medical Oncology Specialist, Ankara Numune Eğitim ve Araştırma Hastanesi (2008-2010)
Military Service (Medical Lieutenant), Department of Medical Oncology - Gülhane Askeri Tıp Akademisi (2007-2008)
Medical Oncology Subspecialty Resident, Ankara Numune Eğitim ve Araştırma Hastanesi (2003-2006)
Internal Medicine Resident, Ankara Numune Eğitim ve Araştırma Hastanesi (1998-2003)

Ozberk U, Esen SA, Sekmek S, Seven I, Bal O, Algin E, Yucel S, Uncu D. Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivity. Anticancer Drugs. doi: 10.1097/CAD.0000000000001798, 2025.
Bayram D, Erdat EC, Çelebi SN, Türk S, Sekmek S, Perkin P, Esen SA, Uçar G, Şendur MAN, Uncu D, Köş FT, Civelek B. The Combined ALBI-FIB-4 Score for Prognostic Stratification in Hepatocellular Carcinoma: A Single Center Retrospective Study. J Hepatocell Carcinoma. 12:2811-2823, 2025.
Seven İ, Karahan İ, Köş FT, Sekmek S, Bayram D, Uçar G, Uncu D. Clinicopathological features of the patients with human epidermal growth factor receptor immunohistochemistry 2+ early stage breast cancer. Ann Clin Anal Med. Doi: 10.4328/ACAM.22464, 2025.
Majıdova N, Arpacı E, Akıncı MB, Uncu D, Uçar G. Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study. J Clin Med. 14, Doi: 10.3390/jcm14124189, 2025.
Sekmek S, Mehtiyev M, Bayram D, Uçar G, Bal Ö, Algın E, Köş FT, Civelek B, Uncu D. CDK4-6 Inhibitors: Evaluation of Efficacy in Cases of Hormone Receptor-Positive HER2-Negative Breast Cancer with Only Bone Metastasis. J Oncol Sci. 11, Doi: 10.37047/jos.galenos.2024.2024.103871, 2025.